Sheffield Pharmaceuticals LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 170 Broad Street, New London, Connecticut (CT) 06320, United States (USA)
- Operations here
- analysislabelmanufacture
- FDA identifiers
- FEI 1210513 · DUNS 151177797
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-06-18
- VAIDrug Quality Assurance2018-09-25
- VAIBioresearch Monitoring2016-02-18
- VAIDrug Quality Assurance2015-03-19
- VAIDrug Quality Assurance2012-04-13
- VAIUnapproved and Misbranded Drugs2012-04-13
- VAIDrug Quality Assurance2010-12-02
- NAIDrug Quality Assurance2009-09-16
Drugs this plant is listed as making
4 distinct drugs across 8 products name this site in their FDA label.
- 1.1% Sodium FluorideCypress Pharmaceutical, Inc.
- 1.1% Sodium Fluoride Prescription Dental CreamCypress Pharmaceutical, Inc.
- Sodium FluorideSheffield Pharmaceuticals LLC
- Sodium Fluoride1.1%, Potassium Nitrate 5%Sheffield Pharmaceuticals LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.